C-reactive protein and cardiovascular disease in people with diabetes

被引:16
作者
Xu, Yin [1 ]
Whitmer, Kyra
机构
[1] Univ Cincinnati, Coll Nursing, Cincinnati, OH USA
[2] Univ Cincinnati, Inst Nursing Res, Cincinnati, OH USA
关键词
D O I
10.1097/00000446-200608000-00027
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
OVERVIEW. Having both diabetes and an elevated C-reactive protein (CRP) level compounds one's risk of developing cardiovascular disease, for which people with diabetes are at particularly high risk. CRP is both a biomarker for infectious and noninfectious disorders associated with inflammation and a risk factor for such conditions. Many researchers now believe that the protein also plays a role in the disease processes. The American Heart Association and the Centers for Disease Control and Prevention recently defined three cardiovascular risk categories relative to CRP levels. This article reviews the relevant literature and explores how CRP levels can be used in cardiovascular disease risk assessment, prevention, and treatment.
引用
收藏
页码:66 / 72
页数:7
相关论文
共 45 条
  • [1] *AM DIAB ASS, COMPL DIAB US
  • [2] Is serum C-reactive protein concentration correlated with HbA1c and insulin resistance in Type 2 diabetic men with or without coronary heart disease?
    Bahceci, M
    Tuzcu, A
    Ogun, C
    Canoruc, N
    Iltimur, K
    Aslan, C
    [J]. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2005, 28 (02) : 145 - 150
  • [3] The relation of markers of inflammation to the development of glucose disorders in the elderly - The cardiovascular health study
    Barzilay, JI
    Abraham, L
    Heckbert, SR
    Cushman, M
    Kuller, LH
    Resnick, HE
    Tracy, RP
    [J]. DIABETES, 2001, 50 (10) : 2384 - 2389
  • [4] Dietary factors that promote or retard inflammation
    Basu, A
    Devaraj, S
    Jialal, I
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2006, 26 (05) : 995 - 1001
  • [5] Potential cost-effectiveness of C-reactive protein screening followed by targeted statin therapy for the primary prevention of cardiovascular disease among patients without overt hyperlipidemia
    Blake, GJ
    Ridker, PM
    Kuntz, KM
    [J]. AMERICAN JOURNAL OF MEDICINE, 2003, 114 (06) : 485 - 494
  • [6] Projected life-expectancy gains with statin therapy for individuals with elevated C-reactive protein levels
    Blake, GJ
    Ridker, PM
    Kuntz, KM
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 40 (01) : 49 - 55
  • [7] Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
    Cleeman, JI
    Grundy, SM
    Becker, D
    Clark, LT
    Cooper, RS
    Denke, MA
    Howard, WJ
    Hunninghake, DB
    Illingworth, DR
    Luepker, RV
    McBride, P
    McKenney, JM
    Pasternak, RC
    Stone, NJ
    Van Horn, L
    Brewer, HB
    Ernst, ND
    Gordon, D
    Levy, D
    Rifkind, B
    Rossouw, JE
    Savage, P
    Haffner, SM
    Orloff, DG
    Proschan, MA
    Schwartz, JS
    Sempos, CT
    Shero, ST
    Murray, EZ
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19): : 2486 - 2497
  • [8] Body mass index, diabetes, and C-reactive protein among US adults
    Ford, ES
    [J]. DIABETES CARE, 1999, 22 (12) : 1971 - 1977
  • [9] Population distribution of high-sensitivity C-reactive protein among US men: Findings from National Health and Nutrition Examination Survey 1999-2000
    Ford, ES
    Giles, WH
    Myers, GL
    Mannino, DM
    [J]. CLINICAL CHEMISTRY, 2003, 49 (04) : 686 - 690
  • [10] Prevalence of the metabolic syndrome among US adults - Findings from the Third National Health and Nutrition Examination Survey
    Ford, ES
    Giles, WH
    Dietz, WH
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (03): : 356 - 359